Results 231 to 240 of about 1,672,197 (320)

A Case Series of Hypermucoid Klebsiella pneumoniae Liver Abscess in Caucasian Americans Without Travel History: An Epidemiologic Shift?

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Hypervirulent Klebsiella pneumoniae (hvKp) is an emerging cause of community‐acquired pyogenic liver abscess (PLA), classically described in East and Southeast Asia. We report two cases of hvKp‐associated PLA in Caucasian women of American origin with no history of international travel, animal exposure, or Asian food consumption. Both patients
Krishna Sai Kiran Sakalabaktula, Sameer Kumar Majety, Sri Ratna Divya Nanduri, Divya Durga, David Kreps, Devi Prasad Botu, Gopichand Muppana   +6 more
wiley   +1 more source

Culture media affects accuracy of prediction of metallo-β-lactamases mediated resistance to imipenem. [PDF]

PLoS One
Chen K, Miller S, Goy K, Lam T, Maeusli M, She R, Spellberg B, Luna B.   +7 more
europepmc   +1 more source

Escherichia coli‐Associated Infectious Aortitis Complicated by Abdominal Aortic Aneurysm and Diverticulitis Treated With Covered Endovascular Reconstruction of the Aortic Bifurcation

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Infectious aortitis caused by Escherichia coli is exceedingly rare and associated with high mortality. We report a 76‐year‐old man presenting with nonspecific abdominal symptoms and E. coli bacteremia, complicated by an infrarenal eccentric saccular abdominal aortic aneurysm and diverticulitis.
Ching‐Chou Pai, Ya‐Ting Chuang, Hua‐Yu Lin, Tao‐An Chen   +3 more
wiley   +1 more source

AmpC β-lactamases: A key to antibiotic resistance in ESKAPE pathogens. [PDF]

Cell Surf
Pandey D, Gupta I, Gupta D.
europepmc   +1 more source

Biomarkers of Drug‐Induced Kidney Injury: Use in Clinical Trials and Recent Examples of Impact on Drug Development

Clinical Pharmacology &Therapeutics, Volume 119, Issue 3, Page 608-617, March 2026.
This manuscript describes the scope of implementation and impact of a regulatory agency‐qualified panel of six urine biomarkers on drug development, the process for which was conducted and funded by the Critical Path Institute, the Foundation for the National Institutes of Health, and the United States Food and Drug Administration.
Tanja S. Zabka, Michael Lawton, Tom Chu, Gary S. Friedman, Katrina Peron, Stefan R. Sultana, Warren E. Glaab, Nicholas M. P. King   +7 more
wiley   +1 more source

A unified annotation scheme for class D β-lactamases. [PDF]

Antimicrob Agents Chemother
Page MGP.
europepmc   +1 more source

Two variants of transferrable extended-spectrum TEM-β-lactamase successively isolated from a clinicalEscherichia coliisolate [PDF]

FEMS Microbiology Letters, 1992
G. Vedel, C. Mabilat, S. Goussard, B. Picard, G. Fournier, L. Gilly, G. Paul, A. Philippon   +7 more
openaire   +1 more source

Effect of surgical antimicrobial prophylaxis duration for colic surgery on complications and resistome

Equine Veterinary Journal, Volume 58, Issue 2, Page 390-403, March 2026.
Abstract Background Based on human studies, surgical antimicrobial (AMD) prophylaxis (SAP) beyond 24 h is unnecessary and potentially detrimental. Objective To compare clinical and microbiological outcomes in patients receiving 24‐ or 72‐h of SAP for colic surgery. Study Design Prospective randomised clinical trial.
Louise L. Southwood, Alicia Long, Jairo Perez, Scott Daniel, Kyle Bittinger, Maia Aitken, Laurel Redding   +6 more
wiley   +1 more source

Ambler class C-type β-lactamases and porin alterations in Enterobacter cloacae complex and Klebsiella aerogenes in the Netherlands, 2012-2023. [PDF]

BMC Microbiol
van Gorp E, Lansu S, Wielders CCH, de Haan A, Godeke GJ, Witteveen S, Bos J, Landman F, Ouw M, Wunderink HF, van Meer MPA, van der Zwet W, Notermans DW, Hendrickx APA, van Arkel ALE, Leversteijn-van Hall MA, van den Bijllaardt W, van Mansfeld R, van Dijk K, Zwart B, Diederen BMW, Berkhout H, Ott A, Waar K, Ang W, da Silva J, Vlek ALM, Stohr JJJM, Bode LGM, Jansz A, Paltansing S, van Griethuysen AJ, Lo Ten Foe JR, van Trijp MJCA, Wong M, Muller AE, van der Linden MPM, van Rijn M, Debast SB, Kolwijck E, Al Naiemi N, Schulin T, Dinant S, van Mens SP, Melles DC, Stuart JWTC, Gruteke P, van Dam AP, Maat I, Maraha B, Sinnige JC, van der Vorm E, van Meer MPA, de Graaf M, de Jong E, Vainio SJ, Heikens E, den Reijer M, Dorigo-Zetsma JW, Troelstra A, Bathoorn E, de Vries J, van Dam DW, de Brauwer EIGB, Steingrover R, Koene F, Oliveira Dos Santos C.   +66 more
europepmc   +1 more source

Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?

Antimicrobial Agents and Chemotherapy, 2017
S. Marshall, A. Hujer, Laura J. Rojas, K. Papp-Wallace, R. Humphries, B. Spellberg, K. Hujer, Emma K. Marshall, S. Rudin, F. Pérez, B. Wilson, Ronald B Wasserman, Linda Chikowski, D. Paterson, A. Vila, D. van Duin, B. Kreiswirth, H. Chambers, V. Fowler, M. Jacobs, M. Pulse, W. Weiss, R. Bonomo   +22 more
semanticscholar   +1 more source